Ageing and Dementia: Journal of Neural Transmission. Supplementa, cartea 53
Editat de Kurt Jellinger, Franz Fazekas, Manfred Windischen Limba Engleză Hardback – 15 iul 1998
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1432.90 lei 43-57 zile | |
SPRINGER VIENNA – 13 iul 1998 | 1432.90 lei 43-57 zile | |
Hardback (1) | 481.82 lei 22-36 zile | +65.50 lei 5-11 zile |
SPRINGER VIENNA – 15 iul 1998 | 481.82 lei 22-36 zile | +65.50 lei 5-11 zile |
Din seria Journal of Neural Transmission. Supplementa
- 5% Preț: 1052.61 lei
- 5% Preț: 423.12 lei
- Preț: 389.88 lei
- 5% Preț: 360.86 lei
- 5% Preț: 712.60 lei
- 5% Preț: 365.61 lei
- Preț: 379.68 lei
- 5% Preț: 376.43 lei
- Preț: 380.45 lei
- 15% Preț: 665.73 lei
- 5% Preț: 990.01 lei
- 5% Preț: 368.73 lei
- 5% Preț: 373.84 lei
- Preț: 391.22 lei
- 15% Preț: 643.34 lei
- Preț: 381.59 lei
- 5% Preț: 394.32 lei
- 5% Preț: 374.78 lei
- Preț: 397.97 lei
- 5% Preț: 379.33 lei
- 5% Preț: 364.33 lei
- 5% Preț: 372.97 lei
- 5% Preț: 372.19 lei
- 5% Preț: 387.02 lei
- 5% Preț: 382.06 lei
- 5% Preț: 367.47 lei
- 5% Preț: 698.36 lei
- 18% Preț: 1400.35 lei
- 5% Preț: 1314.97 lei
- 5% Preț: 1428.71 lei
- 5% Preț: 1095.73 lei
- 5% Preț: 714.46 lei
- 5% Preț: 1113.11 lei
- 5% Preț: 1015.42 lei
- 5% Preț: 719.74 lei
- 5% Preț: 1381.89 lei
- 5% Preț: 1304.04 lei
- 5% Preț: 1980.17 lei
Preț: 481.82 lei
Preț vechi: 507.18 lei
-5% Nou
Puncte Express: 723
Preț estimativ în valută:
92.22€ • 95.04$ • 77.86£
92.22€ • 95.04$ • 77.86£
Carte disponibilă
Livrare economică 10-24 februarie
Livrare express 24-30 ianuarie pentru 75.49 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783211831151
ISBN-10: 3211831150
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 31 mm
Greutate: 1.45 kg
Ediția:1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
ISBN-10: 3211831150
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 31 mm
Greutate: 1.45 kg
Ediția:1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies.- Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study).- Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study.- The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates.- Cognitive correlates of cerebral white matter changes.- Concepts on the prognostic significance of white matter changes.- Difficulties in the clinical diagnosis of vascular dementia and dementia of the Alzheimer type — comparison of clinical classifications.- Problems of differential diagnosis between depressive pseudo- dementia and Alzheimer’s disease.- The neuropathological diagnosis of Alzheimer disease.- The progression of the lesions in Alzheimer disease: insights from a prospective clinico- pathological study.- Evolution of neuronal changes in the course of Alzheimer’s disease.- The cytoskeleton in Alzheimer disease.- Mechanisms of synaptic pathology in Alzheimer’s disease.- Proteolytic processing of Alzheimer’s disease associated proteins.- Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.- Presenilins and Alzheimer’s disease: the role of A?42.- Biological markers for the diagnosis of Alz- heimer’s disease.- Apolipoprotein E4, cholinergic integrity and the pharmaco- genetics of Alzheimer’s disease.- Cerebrospinal fluid levels of A?42 and tau: potential markers of Alzheimer’s disease.- Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing.- Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia.- Current diagnostic methods andoutcome variables for clinical investigation of Alzheimer’s disease.- Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs.- The role of glutamate in dementia.- Neurotrophic activities and therapeutic experience with a brain-derived peptide preparation.- Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats.- The influence of Cerebrolysin® and E021 on spatial navigation of 24-month-old rats.- Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors.- Antioxidant systemic effect of short-term Cerebrolysin® administration.- Can Cerebrolysin® influence chronic deterioration of spatial learning and memory?.- Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.- Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro.- Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro.- Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.